|
US3132171A
(en)
|
1962-06-18 |
1964-05-05 |
Strong Cobb Arner Inc |
3, 4-diphosphatophenyl-alanine and process for making same
|
|
US3939253A
(en)
|
1973-11-02 |
1976-02-17 |
Interx Research Corporation |
Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease
|
|
US3891696A
(en)
|
1973-11-02 |
1975-06-24 |
Interx Research Corp |
Novel, transient pro-drug forms of l-dopa
|
|
US3998799A
(en)
|
1973-11-02 |
1976-12-21 |
Interx Research Corporation |
Novel, transient pro-drug forms of l-dopa
|
|
US4035507A
(en)
|
1975-04-17 |
1977-07-12 |
Interx Research Corporation |
Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease
|
|
US4065566A
(en)
|
1975-04-17 |
1977-12-27 |
Interx Research Corporation |
N-Nicotinoyl-3,4-dinicotinoyloxy-L-phenylalanine and derivatives pharmaceutical compositions and methods containing same
|
|
US4163058A
(en)
|
1977-04-22 |
1979-07-31 |
Interx Research Corporation |
Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof
|
|
US4618484A
(en)
|
1983-03-30 |
1986-10-21 |
Yale University |
Composition and method for treatment of melanomas
|
|
US4508706A
(en)
|
1983-03-30 |
1985-04-02 |
Yale University |
Composition for increasing melanin in mammalian skin and hair
|
|
IT1213182B
(it)
|
1984-06-25 |
1989-12-14 |
Simes |
Derivati di composti a struttura catecolamminica.
|
|
IT1200427B
(it)
|
1985-03-22 |
1989-01-18 |
Afros Spa |
Procedimento ed impianto per lo stampaggio di pezzi in materiale plastico espanso,con parti o inserti preformati a spruzzo nello stesso stampo di formatura
|
|
JPH02138A
(ja)
|
1987-09-18 |
1990-01-05 |
Banyu Pharmaceut Co Ltd |
Ｌ‐ドーパ誘導体
|
|
IT1226727B
(it)
|
1988-07-29 |
1991-02-05 |
Simes |
Farmaci precursori della dopamina.
|
|
DE69016688T2
(de)
|
1989-04-20 |
1995-10-05 |
Zambon Spa |
Dopamin-Medikament-Vorstufe.
|
|
GB9102812D0
(en)
|
1991-02-11 |
1991-03-27 |
Enzymatix Ltd |
Compounds
|
|
IT1255471B
(it)
|
1992-07-30 |
1995-11-02 |
Zambon Spa |
Derivati di catecolammine,processo per la loro preparazione e composizioni farmaceutiche che li contengono
|
|
SE9203594D0
(sv)
|
1992-11-30 |
1992-11-30 |
Christer Nystroem |
Laekemedel i dispersa system
|
|
US5874468A
(en)
*
|
1996-12-26 |
1999-02-23 |
Yissum |
Brain targeted low molecular weight hydrophobic antioxidant compounds
|
|
AU1457299A
(en)
|
1997-11-12 |
1999-05-31 |
Ariad Pharmaceuticals, Inc. |
Novel signal transduction inhibitors, compositions containing them
|
|
US6365180B1
(en)
|
1998-01-20 |
2002-04-02 |
Glenn A. Meyer |
Oral liquid compositions
|
|
US6204257B1
(en)
|
1998-08-07 |
2001-03-20 |
Universtiy Of Kansas |
Water soluble prodrugs of hindered alcohols
|
|
CA2490626A1
(en)
|
2002-06-20 |
2003-12-31 |
Nippon Suisan Kaisha, Ltd. |
Prodrug, medicinal utilization thereof and process for producing the same
|
|
AU2003293423A1
(en)
|
2002-12-06 |
2004-06-30 |
Xenoport, Inc. |
Carbidopa prodrugs and uses thereof
|
|
EP1596808A4
(en)
|
2003-02-07 |
2007-04-04 |
Yissum Res Dev Co |
L-DOPA AMID DERIVATIVES AND THEIR USE
|
|
CN1845728B
(zh)
|
2003-08-29 |
2013-06-19 |
转化医药公司 |
包含左旋多巴和卡比多巴的药物组合物
|
|
JP5160786B2
(ja)
|
2003-08-29 |
2013-03-13 |
トランスフォーム・ファーマシューティカルズ・インコーポレイテッド |
医薬組成物及びレボドパ及びカルビドパの使用方法
|
|
WO2005041925A2
(en)
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Compositions and dosage forms for enhanced absorption
|
|
US7342131B2
(en)
|
2004-06-04 |
2008-03-11 |
Xenoport, Inc. |
Levodopa prodrugs, and compositions and uses thereof
|
|
ES2402552T3
(es)
|
2004-07-06 |
2013-05-06 |
Abbott Laboratories |
Profármacos de inhibidores de proteasa de VIH
|
|
SE0401842D0
(sv)
|
2004-07-12 |
2004-07-12 |
Dizlin Medical Design Ab |
Infusion and injection solution of levodopa
|
|
EP1959948B1
(en)
|
2005-12-05 |
2012-07-18 |
XenoPort, Inc. |
Levodopa prodrug mesylate, compositions thereof, and uses thereof
|
|
RU2484815C2
(ru)
|
2006-05-31 |
2013-06-20 |
Зольвай Фармасьютиклз Гмбх |
Продолжительное 24-часовое введение в кишечник леводопа/карбидопа
|
|
KR20090033871A
(ko)
|
2006-06-16 |
2009-04-06 |
솔베이 파마슈티칼스 비. 브이 |
비페프루녹스 및 ｌ-ｄｏｐａ를 포함하는 병용 제제
|
|
TW200843732A
(en)
|
2006-12-21 |
2008-11-16 |
Xenoport Inc |
Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
|
|
GB0713189D0
(en)
|
2007-07-06 |
2007-08-15 |
Proximagen Ltd |
Amino acid derivatives
|
|
AU2009211028B2
(en)
*
|
2008-02-06 |
2013-12-05 |
Wockhardt Research Centre |
Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
|
|
JP5757864B2
(ja)
|
2008-05-20 |
2015-08-05 |
ニューロジェシックス， インコーポレイテッド |
水溶性アセトアミノフェン類似体
|
|
US20130253056A1
(en)
|
2009-05-19 |
2013-09-26 |
Neuroderm, Ltd. |
Continuous Administration of Levodopa and/or Dopa Decarboxylase Inhibitors and Compositions for Same
|
|
RU2559083C9
(ru)
|
2009-05-19 |
2016-01-20 |
Неуродерм Лтд |
Композиции для непрерывного введения ингибиторов допа-декарбоксилазы
|
|
AU2010291927A1
(en)
|
2009-09-14 |
2012-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Methods for treating psoriasis
|
|
WO2011056240A2
(en)
|
2009-11-09 |
2011-05-12 |
Xenoport, Inc. |
Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
|
|
KR101868326B1
(ko)
|
2010-03-04 |
2018-06-19 |
오리온 코포레이션 |
파킨슨병의 치료를 위한 레보도파, 카르비도파 및 엔타카폰의 용도
|
|
WO2011109767A2
(en)
|
2010-03-04 |
2011-09-09 |
University Of Notre Dame Du Lac |
Gelatinase inhibitors and prodrugs
|
|
CA2801917C
(en)
|
2010-06-03 |
2017-04-25 |
Abbvie Biotechnology Ltd |
Uses and compositions for treatment of hidradenitis suppurativa (hs)
|
|
CN110123743A
(zh)
|
2010-11-15 |
2019-08-16 |
纽罗德姆有限公司 |
L-多巴、多巴脱羧酶抑制剂、儿茶酚-o-甲基转移酶抑制剂及其组合物的连续施用
|
|
CA2818161A1
(en)
|
2010-12-02 |
2012-06-07 |
Ono Pharmaceutical Co., Ltd. |
Novel compound and medical use thereof
|
|
BR112013014304A2
(pt)
|
2010-12-10 |
2016-07-19 |
Synagile Corp |
composições de pró-fármaco levodopa infundíveis subcutaneamente e método de infusão
|
|
US8765189B2
(en)
|
2011-05-13 |
2014-07-01 |
Howmedica Osteonic Corp. |
Organophosphorous and multivalent metal compound compositions and methods
|
|
RU2677278C2
(ru)
|
2013-03-13 |
2019-01-16 |
Неуродерм Лтд |
Способ лечения болезни паркинсона
|
|
BR112015022896B1
(pt)
|
2013-03-15 |
2022-08-23 |
Chongxi Yu |
Composto de fármacos de alta penetração, composição farmacêutica e seus usos para o tratamento de doenças de parkinson
|
|
US10258585B2
(en)
|
2014-03-13 |
2019-04-16 |
Neuroderm, Ltd. |
DOPA decarboxylase inhibitor compositions
|
|
EP3116475B1
(en)
|
2014-03-13 |
2020-11-04 |
Neuroderm Ltd |
Dopa decarboxylase inhibitor compositions
|
|
MX393568B
(es)
*
|
2014-10-21 |
2025-03-24 |
Abbvie Inc |
Profarmacos de carbidopa y l-dopa y metodos de uso
|
|
MA41377A
(fr)
|
2015-01-20 |
2017-11-28 |
Abbvie Inc |
Gel intestinal de lévodopa et de carbidona et procédés d'utilisation
|
|
JP2019515908A
(ja)
|
2016-04-20 |
2019-06-13 |
アッヴィ・インコーポレイテッド |
カルビドパ及びｌ−ドパプロドラッグ並びに使用方法
|
|
US20240024338A1
(en)
|
2016-04-20 |
2024-01-25 |
Abbvie Inc. |
Carbidopa and l-dopa prodrugs and methods of use
|
|
EP3487843A1
(en)
|
2016-07-22 |
2019-05-29 |
Syngenta Participations AG |
Microbiocidal oxadiazole derivatives
|
|
EP3518920A1
(en)
|
2016-09-29 |
2019-08-07 |
Berlirem GmbH |
L-dopa derivatives for the treatment of neurological diseases
|
|
WO2018154447A1
(en)
|
2017-02-21 |
2018-08-30 |
Neuroderm Ltd |
Dopa decarboxylase inhibitor compositions
|
|
UY38473A
(es)
|
2018-11-15 |
2020-06-30 |
Abbvie Inc |
Formulaciones farmacéuticas para una administración subcutánea
|
|
US11331293B1
(en)
|
2020-11-17 |
2022-05-17 |
Neuroderm, Ltd. |
Method for treatment of Parkinson's disease
|
|
US11213502B1
(en)
|
2020-11-17 |
2022-01-04 |
Neuroderm, Ltd. |
Method for treatment of parkinson's disease
|
|
AU2022352845A1
(en)
|
2021-10-27 |
2024-04-11 |
Abbvie Inc. |
Subcutaneously administered foslevodopa/foscarbidopa treatments for advanced parkinson's disease
|